LSTA icon

Lisata Therapeutics
LSTA

Overview Fund Activity

45 hedge funds and large institutions have $3.55M invested in Lisata Therapeutics in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 17 reducing their positions, and 9 closing their positions.

Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$124K
2
RJA
2
Raymond James & Associates
Florida
$48K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$979K
4
Citadel Advisors
4
Citadel Advisors
Florida
$23K
5
UBS Group
5
UBS Group
Switzerland
$19K

Top Sellers

1
GPP
1
Great Point Partners
Connecticut
$1.28M
2
Millennium Management
2
Millennium Management
New York
$0
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$37K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
CG
5
Caprock Group
Idaho
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
51
Barclays
United Kingdom
$0 600 – –
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$0 203 – –
PRCM
53
Pine River Capital Management
Minnesota
$0 1,381,250 – –
CI
54
Cowen Inc
New York
$0 22,500 +22,500 New
1 2
3